- Home
- RGNX vs PFIS Comparison
RGNX vs PFIS Comparison
Compare RGNX & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | PFIS |
|---|---|---|
| Founded | 2008 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 499.8M |
| IPO Year | 2015 | 1998 |
Fundamental Metrics
Financial Performance| Metric | RGNX | PFIS |
|---|---|---|
| Price | $8.38 | $53.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $28.75 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 794.1K | 35.6K |
| Earning Date | 03-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.70% |
| EPS Growth | 18.08 | ★ 493.94 |
| EPS | N/A | ★ 5.88 |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $50.05 | $12.01 |
| Revenue Next Year | $23.31 | $5.85 |
| P/E Ratio | ★ N/A | $9.05 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.04 | $39.00 |
| 52 Week High | $16.19 | $57.71 |
Technical Indicators
Market Signals| Indicator | RGNX | PFIS |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 51.08 |
| Support Level | $7.81 | $49.98 |
| Resistance Level | $9.28 | $53.71 |
| Average True Range (ATR) | 0.47 | 1.62 |
| MACD | 0.03 | 0.14 |
| Stochastic Oscillator | 46.82 | 65.20 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.